Cowen And Company, LLC Abb Vie Inc. Call Options Transaction History

Cowen And Company, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $4.26 Million - $4.83 Million	-40,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $4.21 Million - $4.69 Million	40,000 New	40,000 $76,000
Q1 2021 May 04, 2021	SELL	$102.3 - $112.62 $9.86 Million - $10.9 Million	-96,400 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $4.56 Million - $6.16 Million	56,700 Added 142.82%	96,400 $1.04 Million
Q3 2020 Nov 03, 2020	SELL	$85.91 - $100.83 $3.46 Million - $4.06 Million	-40,300 Reduced 50.38%	39,700 $12,000
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $5.77 Million - $7.22 Million	80,000 New	80,000 $1.29 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.